SyntekaBio Extends Largest Shareholder’s Share Pledge to Nov. 30, 2026
Bitget2026/10/30 08:55- SyntekaBio corrected its disclosure to extend the share collateral period to November 30, 2026, from October 30, 2026.
- The agreement pledges 2,800,000 shares against KRW 2.85 billion in borrowings, with collateral valued at KRW 5.04 billion.
- Full enforcement would reduce the largest shareholder’s stake to 3.13% from 14.67%, potentially triggering a change in the largest shareholder.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
US LNG exports surged to the second-highest level in history in October, with Europe accounting for 60% of demand
In October, U.S. LNG exports reached 7.92 million metric tons, only slightly below the record high of 8.01 million metric tons set in April this year, and saw a significant month-on-month increase from 7.12 million metric tons in September. Europe continues to expand its purchases of U.S. LNG, with its share surging 8 percentage points from the previous month to 60%. Analysts point out that Europe's underground gas storage facilities are nearly full; if temperatures in the Northern Hemisphere remain normal this winter, high global inventories may put downward pressure on prices.
BUZZ-Vertex Pharmaceuticals shares rise after raising 2026 revenue forecast
Tenuis: Apple achieves growth in most markets in the fourth fiscal quarter
Crypto prices
More
